The HeMoStep kit is an in vitro immunoassay for the quantitative measurement of blood contamination of cerebrospinal fluid (CSF) samples by flow cytometry.
The intended use of the assay is to quantify the contamination of CSF samples with peripheral blood, helping, in combination with other tests such as flow cytometry (FCM) and cytology (CC), to the accurate interpretation of the results from the analysis of this type of samples (CSF) improving the diagnosis of leptomeningeal disease in patients with B and T cell lymphomas and acute leukemias of lymphoid and myeloid origin.